You are currently viewing a new version of our website. To view the old version click .
Scientia Pharmaceutica
  • Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
  • Article
  • Open Access

21 January 2002

Syrltllesis and Alltituberculous activity of N-Mannich bases of 3-[4-(4 chloropheny1)-6-(4-methylphesyl) pyrimidin-2-yl] iminoisatin derivatives

,
,
and
1
Medicirlal Chernistry Research Laboratoly, Phannacy Group, Birla Institute of Technology and Sciences. Pilani, Rajastban-33303 1, (INDIA)
2
Department of I'halnlaceutics, Institute of Technology, Banalas Hindu University, Vasanasi-221005, (INDIA)
3
National lrlstitute of Allergy and Infectious Diseases, TAACF, Southern Research Institute, 2000, 9th Avenue South, Birmingham, AL 35255, (USA).
*
Author to whom correspondence should be addressed.

Simple Summary

Isatin, its 5-chloro and 5-bromo derivatives have beer) reacted with 4-(4-chloropheny1)-6-(4-methylphenyl)-2-aminopyrimidine to form Schiff bases and the N-Mannich bases of these compounds were syrlthesized by reacting thern with folmaldehyde and several secondary arnines. The cornpoullds were evaluated in vitro against Mycobacterium tuberculosis H37Rv at 6.25 μg/ml in BACTEC 12l3 tnediunl using the BACTEC 460 radiometric system. Among the cotnpounds tested 3-[4-(4-ch1orophenyl)-6-(4- methylphenyl) pyrimidin-2-yl]iminoisatin (Sl) showed prornising activity with 97% inhibition at a concentration of 6.25 μg/ml.

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Tuberculosis is making a worldwide resurgence [...]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.